文献速递复苏、休克与脓毒症心脑血管急症

日本心源性院外心脏骤停目击者类型与神经功能良好结局的关系

Neurologically favourable outcomes of cardiogenic out-of-hospital cardiac arrest with relation to the type of witness in Japan.
PubMed 文献 · Resuscitation · 2020-05-15
一句话结论日本全国登记数据显示,家庭目击的心源性院外心脏骤停患者1个月神经功能良好结局低于非家庭目击者(校正OR=0.88)。

该回顾性观察研究利用2016年1月1日至12月31日日本全国Utstein登记数据,纳入18岁以上、心源性、有目击者的院外心脏骤停患者24856例,其中家庭目击15139例,非家庭目击9717例(朋友1306例、同事951例、路人997例、其他6463例)。主要终点为心脏骤停后1个月神经功能良好结局。家庭目击组神经功能良好结局显著低于非家庭目击组(OR=0.45,95%CI 0.41-0.49,P<0.001),校正混杂因素后仍较低(OR=0.88,95%CI 0.79-0.99,P=0.03)。亚组分析中,65-84岁女性和≥85岁女性家庭目击者的校正OR略高于非家庭目击者,其余各组非家庭目击者均优于家庭目击者。作者认为,对家庭成员进行基础生命支持教育可能改善目击性心源性院外心脏骤停的预后。

要点

  • 家庭目击的心源性院外心脏骤停患者1个月神经功能良好结局低于非家庭目击者(OR=0.45,95%CI 0.41-0.49,P<0.001)。
  • 校正潜在混杂因素后,家庭目击组神经功能良好结局仍低于非家庭目击组(OR=0.88,95%CI 0.79-0.99,P=0.03)。
  • 亚组分析中,65-84岁女性和≥85岁女性家庭目击者的校正OR略高于非家庭目击者,其余各组非家庭目击者均优于家庭目击者。
  • 作者认为,对家庭成员进行基础生命支持教育可能改善目击性心源性院外心脏骤停的预后。

适用人群与场景

  • 纳入标准:2016年1月1日至12月31日日本全国Utstein登记中,18岁以上、心源性、有目击者的院外心脏骤停患者。
  • 共纳入24856例,其中家庭目击15139例,非家庭目击9717例(朋友1306例、同事951例、路人997例、其他6463例)。

研究设计与关键结果

  • 研究类型:回顾性观察研究,使用2016年1月1日至12月31日日本全国Utstein登记数据。
  • 样本量:共纳入24856例,家庭目击15139例,非家庭目击9717例。
  • 主要终点:心脏骤停后1个月神经功能良好结局。
  • 家庭目击组神经功能良好结局显著低于非家庭目击组(OR=0.45,95%CI 0.41-0.49,P<0.001)。
  • 校正潜在混杂因素后,家庭目击组神经功能良好结局仍低于非家庭目击组(OR=0.88,95%CI 0.79-0.99,P=0.03)。
  • 亚组分析:65-84岁女性和≥85岁女性家庭目击者的校正OR略高于非家庭目击者;其余各组非家庭目击者均优于家庭目击者。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对家庭成员进行基础生命支持教育可能改善目击性心源性院外心脏骤停的预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To assess the current situation and neurologically favourable outcomes after out-of-hospital cardiac arrest (OHCA) with respect to the type of witness.

METHODS: This retrospective observational study used data from the All-Japan Utstein Registry of the Fire and Disaster Management Agency collected between January 1, 2016, and December 31, 2016. Patients with cardiogenic OHCA aged ≥18 years who were witnessed by bystanders were included. The primary outcome measure was a neurologically favourable outcome 1 month after the OHCA.

RESULTS: Among the 123,554 patients with OHCA registered between January 1, 2016, and December 31, 2016, 24,856 patients were included. Of them, 15,139 were witnessed by family, and 9717 were witnessed by non-family (friends, 1306; colleagues, 951; passers-by, 997; others, 6463). When witnessed by family, the rate of neurologically favourable outcomes was significantly lower than that when witnessed by non-family (odds ratio [OR] = 0.45, 95% confidence interval [CI] = 0.41-0.49, P < 0.001). After adjusting for potential confounders, the rate of neurologically favourable outcomes remained lower when OHCA was witnessed by family (OR = 0.88, 95% CI = 0.79-0.99, P = 0.03). However, in subgroup analysis, adjusted ORs for neurologically favourable outcomes were slightly greater for 65-84-year-old women and ≥85-year-old women with family witnesses than for those with non-family witnesses. For all other groups, non-family witnesses outperformed family witnesses.

CONCLUSION: Family-witnessed OHCA events had fewer neurologically favourable outcomes before and after adjusting for confounders. BLS education for family members may lead to improved prognosis of witnessed cardiogenic OHCAs.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Shirakawa K, Kanao K, Saito Y, et al. Neurologically favourable outcomes of cardiogenic out-of-hospital cardiac arrest with relation to the type of witness in Japan. Resuscitation. 2020. PMID: 32422239. doi:10.1016/j.resuscitation.2020.04.039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。